| Gene symbol | HA | Synonyms | None | Type of gene | protein-coding |
| Chromosome | - | Map location | NC_002017.1 (33..1733) | dbXrefs | |
| Description | haemagglutinin | ||||
| GTO ID | GTC1717 |
| Trial ID | NCT03121339 |
| Disease | Seasonal Influenza |
| Altered gene | HA |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | dsRNA |
| Treatment | VXA-A1.1|Ad-HA-dsRNA |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | A Phase 1, Open-Label, Randomized, 2×2 Crossover Study of Pharmacodynamics Comparing the Impact of Tablet Size and Fasting Status With an Oral Human Influenza A/California/04/2009 (H1N1) HA Adenoviral-Vector Based Vaccine and dsRNA Adjuvant |
| Year | 2017 |
| Country | United States |
| Company sponsor | Vaxart |
| Other ID(s) | VXA02-RLT-01 |
| Vector information | |||||||||||
|
|||||||||||
| Cohort1: Fasting Condition | |||||||||
|
|||||||||
| Cohort2: Fed Condition | |||||||||
|
|||||||||